CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP
· Real-Time Price · USD
53.58
0.84 (1.59%)
At close: Sep 05, 2025, 11:34 AM
CRISPR Therapeutics Stock Forecast
Stock Price Forecast
The 16 analysts with 12-month price forecasts for CRSP stock have an median target of 80, with a low estimate of 32 and a high estimate of 120. The median target predicts an increase of 49.31% from the current stock price of 53.58.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 32 | 72.27 | 80 | 120 |
| Change | -40.28% | 34.88% | 49.31% | 123.96% |
Latest Analyst Insight Report
HC Wainwright & Co. has maintained a Buy rating on... Unlock content with Pro Subscription
Updated Aug 07, 2025
| Rating | Feb 25 | Apr 25 | May 25 | Jun 25 | Jul 25 | Aug 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 | 1 |
| Buy | 7 | 1 | 5 | 5 | 2 | 1 |
| Hold | 5 | 0 | 2 | 1 | 0 | 2 |
| Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 1 | 7 | 6 | 2 | 4 |
Financial Forecast this Year
Revenue This Year
32.21M
from 35M
Increased by -8%
Revenue Next Year
156.21M
from 32.21M
Increased by 385.0%
EPS This Year
-6.21
from -4.34
Increased by -43.1%
EPS Next Year
-4.01
from -6.21
Increased by 35.4%